Li, Philip Kam-Tao <br/><br/>
Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.  [electronic resource] 

 -  American journal of kidney diseases : the official journal of the National Kidney Foundation  May 2006 
 - 751-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-6838 
<br/><br/><label>Standard No.: </label>10.1053/j.ajkd.2006.01.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Glomerulonephritis, IGA--drug therapy<br/>Hong Kong<br/>Humans<br/>Male<br/>Tetrazoles--therapeutic use<br/>Valine--analogs & derivatives<br/>Valsartan